5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE FOLLOW DIFFERENT METABOLIC PATHWAYS IN THE INDUCTION OF CELL LETHALITY IN L1210-LEUKEMIA

被引：24

作者：

ROOBOL, C

DEDOBBELEER, GBE

BERNHEIM, JL

机构：

来源：

关键词：

D O I：

10.1038/bjc.1984.116

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：739 / 744

页数：6

共 24 条

[1]

ARDALAN B, 1981, CANCER TREAT REP, V65, P57

[2]

ARDALAN B, 1978, BIOCHEM PHARMACOL, V27, P1

[3]

CHAUDHURI NK, 1958, CANCER RES, V18, P318

[4] THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES [J].

COHEN, SS ;

FLAKS, JG ;

BARNER, HD ;

LOEB, MR ;

LICHTENSTEIN, J .

[5] THYMIDYLATE SYNTHETASE - TARGET ENZYME IN CANCER CHEMOTHERAPY [J].

DANENBERG, PV .

[6]

GLAZER RI, 1980, MOL PHARMACOL, V17, P245

[7]

GLAZER RI, 1980, MOL PHARMACOL, V17, P279

[8]

GLAZER RI, 1979, MOL PHARMACOL, V16, P270

[9]

HARTMANN KU, 1961, J BIOL CHEM, V236, P3006

[10]

HEIDELBERGER C, 1975, HDB EXPT PHARMAKOLOG, V38, P193